| Term 
 | Definition 
 
        | Drugs to treat hyperlipoproteinemia Inhibitors of HMG-CoA reductase, the rate-limiting step in cholesterol synthesis
 Useful as secondary preventative treatment in those with pre-existing CVD or risk of heart disease
 Also improve endothelial function, modulate inflammation, maintain plaque stability & prevent thrombus formation
 |  | 
        |  | 
        
        | Term 
 
        | Cholestyramine (Questran) Colesvelam (Cholestagel, Welchol)
 Colestipol (Colestid)
 |  | Definition 
 
        | Synthetic polymeric resins used as bile acid sequestrants to treat hyperlipoproteinemia Resins bind bile acids in the intestine & prevents reabsorption
 Decreased bile acid levels induces conversion of cholesterol to bile
 Decreases VLDL and LDL, increases HDL
 Side effects include severe constipation
 |  | 
        |  | 
        
        | Term 
 
        | Bezafibrate (Bezalip) Ciprofibrate (Modalim)
 Gemfibrozil (Lopid)
 Fenofibrate (TriCor)
 |  | Definition 
 
        | Fibric acid derivatives Drugs to treat hyperlipoproteinemia
 Activate PPARs, transcription factors that modulate carb and fat metabolism and adipose tissue differentiation
 |  | 
        |  | 
        
        | Term 
 
        | Niasin (vitamin B3)/nicotinic acid |  | Definition 
 
        | Drug to treat hyperlipoproteinemia Binds a GPCR which causes inhibition of fat breakdown
 Reduces the production of triglycerides, VLDL and LDL
 Increases HLDL more than other drugs
 |  | 
        |  |